Back

Opening question

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Controversies in channelopathy Ventricular Arrhythmias and SCD - Pathophysiology and Mechanisms - Ion Channel Disorders EHRA Premium Access EHRA 2018

11 More presentations in this session

Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - PRO
Professor V. Probst (Nantes, FR)
Slides Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - CON
Professor S. Viskin (Tel Aviv, IL)
Slides Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - Rebuttal PRO
Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - Rebuttal CON
Video
Presentation thumbnail
Chairperson conclusion & Closing question
Slides Video

Access the full session

Session thumbnail
Controversies in channelopathy

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources